CELADIN

Welcome to the Brand page for “CELADIN”, which is offered here for Pharmaceutical composition for the treatment of inflammation, cancers, infectious disease, cardiovascular disease, immune dysfunction and viral disease;.

Its status is currently believed to be active. Its class is unavailable. “CELADIN” is believed to be currently owned by “Glycomed Incorporated”.

Owner:
GLYCOMED INCORPORATED
Owner Details
Description:
Pharmaceutical composition for the treatment of inflammation, cancers, infectious disease, cardiovascular disease, immune dysfunction and viral disease;
Categories: PHARMACEUTICAL COMPOSITION TREATMENT